2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness. - Bhimraj A; Falck-Ytter Y; Baden LR; Bedimo R; Cawcutt K; Cheng VC; Chew KW; Chiotos K; Daar ES; Dzierba AL; Glidden DV; Hardy EJ; et al. (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026)